Lentivectors, derived from human immunodeficiency virus-1 (HIV-1), represent a novel investigational and therapeutic tool for targeting hematopoietic progenitor cells. We describe a new protocol whereby we achieved a highly efficient lentiviral transduction of erythroid precursor cells originating from the bone marrow of healthy adults and patients with myelodysplastic syndromes (MDS). CD34
Introduction
Gene transfer in human hematopoietic progenitor and stem cells (HSCs) has much potential, both for the understanding of fundamental mechanisms of hematopoiesis and treatment of its related disorders. In the last few years, lentiviral vectors have emerged as excellent candidates for gene transduction because they can integrate into slowly or non-dividing cells such as HSCs. 1 Oncoretroviral vectors, derived from Moloney murine leukemia virus, for instance, require passage through mitosis in order to be able to integrate into target cells. 2 Until now, lentiviral transduction has mainly been carried out on murine hematopoietic cells, 3 or on hematopoietic cells from human cord blood. [4] [5] [6] [7] We describe a new protocol whereby we achieved a highly efficient lentiviral transduction of erythroid precursor cells from the bone marrow of healthy adults and of patients with low risk myelodysplastic syndrome (MDS) (sideroblastic (SA) and refractory (RA) anemia). These syndromes are characterized by a deficient clonogenic growth and an excessive apoptotic rate of multipotent and primitive erythroid progenitors, leading to ineffective hematopoiesis. [8] [9] [10] [11] The study of low-risk myelodysplastic syndromes is difficult, due to reduced survival of these cells in vitro, inefficient amplification in culture and the lack of animal models. We report here a new approach to investigate these syndromes using lentiviral vectors. Other groups have already reported efficient transduction of erythroblasts with murine oncoretroviruses derived from the Molony murine leukemia virus, 12, 13 but in these studies CD34
+ cells were obtained from human cord blood and transduction was only obtained for a fraction of dividing cells, since these vectors require cells undergoing mitosis in order to integrate. 2 We therefore chose lentivectors to transduct dysplastic erythroid precursors with inefficient and aborted in vitro proliferation, and we were able to demonstrate that constructs with an optimized promoter (cPPT-PGK) constitute excellent candidates for the transduction of these MDS cells.
Materials and methods

Cytokines and antibodies
Erythropoetin (Eprex; Cilag, Schaffhausen, Switzerland), IL-3, stem cell factor, thrombopoetin, Flt-3 ligand (all from Peprotech EC, London, UK) were used for cell cultures at 2 U/ml, 20 ng/ml, 20 ng/ml, 10 ng/ml, and 25 ng/ml, respectively. Antiglycophorin (Dako Diagnostics, Zug, Switzerland), anti-CD71, anti-CD34 and anti-CD45 antibodies (all from BD Biosciences, Heidelberg, Germany) were used for flow cytometric analysis. Corresponding isotype control antibodies were also from BD Biosciences.
Vectors
Production of HIV-derived vectors pseudotyped with the vesicular stomatitis virus (VSV) G envelope protein was achieved by transient cotransfection of three plasmids into 293T cells. 5, 14 VSV G was expressed from pMDG. The HIV-derived packaging construct used was pCMV 8.91. 15 The HIV vector plasmids used in this study contain the self-inactivating modification (SIN), as previously described 16 and the woodchuck hepatitis transcriptional element (WPRE). 17 The PGK (phosphoglycerate kinase) and EF-1 (human elongation factor 1) HIV vector plasmids were a gift from D Trono and were described previously. 5 The cPPT-PGK vector plasmid was a gift 18 from L Naldini. The HIV vector plasmids are derived from the original pHRЈ backbone and express GFP as a reporter. 5, 14 Vector titers were determined by transduction and flow cytometry analysis of GFP expression in HeLa cells, as previously described. 5 Titers were between 2 × 10 7 and 6 × 10 7 HeLa transducing units (TU) per milliliter.
Purification and culture of CD34 + cells
Bone marrow samples were obtained from six adult patients with normal bone marrow and from nine patients with lowrisk myelodysplastic syndrome (three RA, six SA), according to institutional guidelines. After Ficoll-Paque gradient centrifugation, CD34 + cells were isolated with magnetic beads as previously described. 5, 19 The percentage of purified CD34 + cells was 85 ± 10%; contamination with glycophorin + cells was Ͻ2% in all cases. For cell culture, 2.5 × 10 4 cells were seeded in 96-round well plates and grown in IMDM medium (Gibco BRL, Life Technologies, Paisley, UK), supplemented with 10% fetal calf serum (Seromed; Biochrom, Berlin, Germany), erythropoietin/IL-3/stem cell factor (E/I/S) or thrombopoietin/Flt3-ligand/stem cell factor (T/F/S). Cell proliferation was assessed by counting cells after trypan blue dye exclusion staining. Flow cytometry was performed as described 5, 20 after labeling with various antibodies and with 7-amino-actinomycin (Sigma, Buchs, Switzerland) to exclude apoptotic and dead cells.
Transduction of CD34
+ cells
Two different methods were employed. 2.5 × 10 4 purified CD34 + cells were seeded in 96-well plates in 100 l of IMDM + thrombopoietin, as described. 
Immunofluorescence analysis
Cells were stained with the appropriate antibodies, fixed with paraformaldehyde 2%, and a cytospin prepared. Images were made as described previously. 21 
Cell sorting and staining for iron
After 12 days of culture, cells were labeled with anti-glycophorin, then sorted with a cell sorter (FACStar, CMU, Geneva University, Geneva, Switzerland). Subsequently, cytospins were prepared and stained for mitochondrial iron with Prussian blue.
Results and discussion
In vitro generation of erythroid precursors and mature erythrocytes
CD34
+ cells obtained from six normal human adult bone marrow samples were cultured for 20 days in E/I/S. Cells were amplified 96 ± 20-fold (s.d. for standard deviation) after 10 days and 329 ± 56-fold (s.d.) after 20 days; longer periods of culture did not result in any further increase in cell number. At day 20, 88 ± 9% of these cells were glycophorin
− erythroid cells, 10-30% of which lost the CD71 antigen. Accordingly, all stages of erythroblast differentiation were observed, including that of enucleated mature erythrocytes. This protocol generated a higher amount of erythroid cells than previously reported, 5 which involved a preliminary culture in T/F/S before induction in E/I/S (data not shown). Alternatively, CD34
+ cells were cultured for 7 days in T/F/S, followed by E/I/S, as reported previously. 5 Whereas cell proliferation was similar to cells cultured from the beginning in E/I/S (AF = 315 ± 151-fold), the yield of glycophorin
− cells was only 53 ± 6%.
Optimizing transduction efficiency in normal CD34
+ cells
In order to increase the relatively weak transduction levels of erythroid precursors reported so far, 5 we evaluated three complementary approaches using the culture conditions which gave rise to the highest percentage of glycophorin
− cells, ie culture containing E/I/S from culture start: (1) transducing the CD34 + cells at different times of culture (1, 3 and 7 days) (Figure 1a ), (2) using multiplicities of infection (MOIs) from 1 to 10 ( Figure 1b) ; and (3) testing three different lentiviral constructs (Figure 2) . The HIV vector plasmids differed in their internal promoter. EF1␣, PGK 5 and a construct with the PGK-promoter and a central polypurine tract (PGK-cPPT vector) were used. 18 This latter sequence has recently been shown to play an important role in nuclear import 22 thereby increasing transduction efficiency in HSCs. 18, 23 A maximum transduction was achieved with the PGK-cPPT vector at a MOI of 10 when the HSCs were transduced after 3 days of culture in E/I/S (Figure 1) . At a similar MOI, we obtained 68 ± 6% GFP-expressing glycophorin
− cells with the PGK-cPPT vector compared to 38 ± 8% with the PGK vector alone and 44 ± 4% with the vector EF1␣ (values obtained from four independent experiments). Interestingly, GFP expression with the PGKcPPT construct was also much stronger than with the PGK promoter (median GFP intensity of 317 ± 64 vs 35 ± 15), and slightly superior to the EF1-␣ promoter (median GFP intensity 273 ± 18) (Figure 2a) .
The morphology of the transduced cells, as evaluated by Giemsa staining and by immunofluorescence microscopy, showed normal features (Figure 2b ). 
Culture and transduction of CD34 + cells from patients with low-risk myelodysplastic syndromes (MDS)
CD34
+ cells were purified from the bone marrow of six patients with SA and three patients with RA and cultured in E/I/S. Proliferation was low compared to normal adult CD34 
/CD45
− cells was variable and lower than in healthy subjects (mean 34 ± 8% s.e.m., standard error of the mean) in agreement with previous reports 24, 25 (Figure 3a) . Cells from MDS patients were transduced with either EF1␣ or cPPT-PGK vectors, using the optimal conditions described above. In two patients no glycophorin + cells were obtained and Ͼ80% cells were apoptotic when tested after 10 days of culture. Moreover, cell cultures from these patients in T/F/S followed by E/I/S also resulted in a very low proliferation and negligible differentiation into erythroid cells (data not shown). In the seven patient cultures responding to E/I/S, we were able to achieve efficient transduction of 46 ± 9% (s.e.m.) in the erythroid precursors (Figure 3b) . The cPPT-PGK vector which was used for cultures from four patients once again gave superior yields than the EF1␣ vector (59% vs 40%) .
In order to demonstrate that precursors from the myelodysplastic clone were transduced and not only residual normal precursors, we searched for the presence of sideroblasts in transduced erythroid precursors from MDS patients. A FISH analysis for the detection of a chromosomal abnormality would have been uninformative since all samples exhibited a normal karyotype. We therefore isolated glycophorin + /GFP + cells after 12 days of culture in E/I/S by cell sorting from three patients with MDS (three patients with SA) (Figure 4a ) and stained them for mitochondrial iron (Figure 4b ), this being the standard technique for detecting sideroblasts. In each of the three sorted patient samples tested, we detected sideroblastic erythroid precursors (mean 34% ± 9% s.e.m.). Together, these experiments demonstrate that lentiviral vectors are able to efficiently transduce MDS precursors.
In conclusion, our study demonstrates that optimized lentiviral vectors are excellent candidates for the transduction of erythroid precursors of normal adults and of patients suffering from myelodysplastic syndromes. Furthermore, these vectors offer new opportunities for studying the effect of specific genes implicated in the regulation of erythropoiesis. Transduction of dysplastic or deficient HSCs with genes regulating erythroid proliferation and differentiation might therefore constitute a novel and potent tactic to study the complex dysregulations occurring in myelodysplastic syndromes. New perspectives for the treatment for these frequent disorders may be discovered as a result of these studies. 
/GFP
+ cells were fixed and stained for the presence of mitochondrial iron, the hallmark of sideroblasts (dotted arrow). One representative result of three experiments is shown.
